Two leading oncology centers in Shanghai and the US state of California have joined forces in the battle against cancer, signing a strategic cooperation agreement in Anting town, Shanghai's Jiading district on Jan 18.
The Shanghai Cell Therapy Group, a conglomerate located in Jiading that focuses on the development of cell therapy, cell storage, gene testing and other treatments, and Stanford Medicine's Radiation Oncology Center, based in Stanford, CA, have agreed to cooperate on the development of oncotherapy technology.
The cooperation originated from previous exchanges between the two institutions, during which both sides agreed that it is possible to combine radiation therapy and immune therapy to cure cancers.
According to the deal, they plan to build an international radiation oncology and immune therapy research center, as well as a world-leading medical treatment center chain offering a combination of radiation therapy and immune therapy.
The two parties will also hold academic conferences and training programs regularly, and will work together on scientific research for mutual benefit.